Royal Bank of Canada’s Tiziana Life Sciences TLSA Stock Holding History

Royal Bank of Canada’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-112	Closed	–	–	7697
2020 Q4	$0	Buy	+112	New	+$354	﹤0.01%	7289

Other funds holding TLSA

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

AFP

Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return

CAAS

Capital Asset Advisory Services Williamston, Michigan $2.61B AUM 15.59% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada's TLSA Position: Q1 2021 in Review

Royal Bank of Canada sold out of Tiziana Life Sciences (TLSA) in Q1 2021, closing a stake of 112 shares.

Royal Bank of Canada first reported a position in TLSA in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 23 funds tracked by Wall St. Rank hold TLSA as of Q1 2021.

Royal Bank of Canada reported no remaining Tiziana Life Sciences position as of Q1 2021 after selling out during the quarter.
Royal Bank of Canada sold 112 Tiziana Life Sciences shares in Q1 2021.
Royal Bank of Canada first reported a position in Tiziana Life Sciences in Q4 2020 and held it in 1 quarter.
Royal Bank of Canada's Tiziana Life Sciences position peaked at $0 in Q4 2020.
23 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2021.

Based on Royal Bank of Canada's 13F filing for Q1 2021, filed 17 May 2021.